Saturn V Capital Management LP Diversified Active

CIK: 0001964437 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $133,889 (100.0% shares, 0.0% debt)

Holdings (18)

CYMABAY THERAPEUTICS INC 10.6%
Value ($000) $14,209 Shares 1,629,464 Est. Cost $3.60 Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 8.9%
Value ($000) $11,901 Shares 741,043 Est. Cost $17.76 Unrealized +4.2%
CHINOOK THERAPEUTICS INC 8.8%
Value ($000) $11,733 Shares 506,818 Est. Cost $17.10 Unrealized
HORIZON THERAPEUTICS PLC 8.1%
Value ($000) $10,829 Shares 99,217 Est. Cost $90.31 Unrealized
BIIB BIOGEN INC(NSM) 7.8%
Value ($000) $10,415 Shares 37,459 Est. Cost $277.87 Unrealized -0.4%
CYTK CYTOKINETICS INC 7.4%
Value ($000) $9,955 Shares 282,886 Est. Cost $42.30 Unrealized -3.6%
BCRX BIOCRYST PHARMACEUTICALS INC 7.2%
Value ($000) $9,704 Shares 1,163,535 Est. Cost $10.46 Unrealized -7.9%
MORPHIC HOLDING INC 6.9%
Value ($000) $9,283 Shares 246,616 Est. Cost $27.33 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 6.6%
Value ($000) $8,819 Shares 1,121,982 Est. Cost $6.11 Unrealized +22.1%
ASND ASCENDIS PHARMA A/S - ADR 6.2%
Value ($000) $8,278 Shares 77,210 Est. Cost $115.24 Unrealized
APLS APELLIS PHARMACEUTICALS INC 6.1%
Value ($000) $8,124 Shares 123,165 Est. Cost $53.04 Unrealized +8.8%
ITEOS THERAPEUTICS INC 4.9%
Value ($000) $6,542 Shares 480,653 Est. Cost $18.55 Unrealized
SAGE THERAPEUTICS INC 4.5%
Value ($000) $6,085 Shares 145,018 Est. Cost $34.39 Unrealized
FOLD AMICUS THERAPEUTICS INC(NMS) 2.1%
Value ($000) $2,864 Shares 258,288 Est. Cost $11.26 Unrealized +9.5%
ARQT ARCUTIS BIOTHERAPEUTICS INC 1.5%
Value ($000) $1,960 Shares 178,217 Est. Cost $17.47 Unrealized -17.2%
2SEVENTY BIO INC 1.3%
Value ($000) $1,756 Shares 172,188 Est. Cost $14.43 Unrealized
ASTRIA THERAPEUTICS INC 1.0%
Value ($000) $1,348 Shares 101,339 Est. Cost $9.18 Unrealized
SCILEX HOLDING CO(NAS) 0.1%
Value ($000) $85 Shares 10,390 Est. Cost $8.20 Unrealized